Brief: Better Therapeutics Strengthens Financial Position Through Amendment To Debt Facility And Implementation Of Cost Reductions

Better Therapeutics

28/11/2023 15:24

Better Therapeutics Inc  BTTX.O :
    * BETTER THERAPEUTICS STRENGTHENS FINANCIAL POSITION THROUGH
AMENDMENT TO DEBT FACILITY AND IMPLEMENTATION OF COST REDUCTIONS
    * BETTER THERAPEUTICS INC - IMPLEMENTING VARIOUS COST-SAVING
MEASURES, INCLUDING COMPANY-WIDE SALARY REDUCTIONS FOR Q1 OF
2024
    * BETTER THERAPEUTICS INC - CONTINUE TO ADVANCE PARTNERING
DISCUSSIONS AND EVALUATE ALL FINANCING OPTIONS AVAILABLE TO US
    * BETTER THERAPEUTICS INC - MEASURES, ALONG WITH OTHER
OPERATIONAL
PLANS, EXPECTED TO IMPROVE FINANCIAL POSITION BY ABOUT $5
MILLION THROUGH Q1 OF 2024
    * BETTER THERAPEUTICS INC - SAVINGS EXPECTED TO EXTEND CASH
RUNWAY
SUFFICIENTLY TO DEMONSTRATE COMMERCIAL TRACTION WITH ASPYRERX IN
TYPE 2 DIABETES

Source text for Eikon:  ID:nBwbK0WZza 
Further company coverage:  BTTX.O